Authoritative Sources Official FDA prescribing information for Wegovy for adverse reactions, warnings, contraindications, and pregnancy information
Price: Rs 40 / StripGet Latest Price Product Details: Metfor 500 mg Metformin Hydrochloride Tablets are an oral antidiabetic medicine commonly prescribed for the management of type 2 diabetes mellitus, working by reducing glucose production in the liver, improving the bodys sensitivity to insulin, and lowering the absorption of sugar from the intestines
It mimics the GLP-1 hormone, which slows digestion, increases insulin release, reduces appetite, and helps regulate blood sugar levels
TRIUMPH-4: Retatrutide Delivers Weight Loss, Knee Osteoarthritis Pain Relief Eli Lilly and Company has announced positive topline results from the phase 3 TRIUMPH-4 clinical trial assessing the safety and efficacy of the 2 largest investigational doses of retatrutide in adults with obesity or overweight and knee osteoarthritis, and without diabetes, as an adjunct to healthy diet and physical activity.1 According to a December 11, 2025, release from the Company, both the 9 mg and 12 mg doses of the first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist met all primary and key secondary endpoints, delivering significant weight loss and improvements in pain and physical function at 68 weeks using both the efficacy and treatment-regimen estimands.1 "People with obesity and knee osteoarthritis often live with pain and restricted mobility, and may eventually require total joint replacement," said Kenneth Custer , PhD, executive vice president and president, Lilly Cardiometabolic Health.1 "We are encouraged by the results of TRIUMPH-4, which highlight the powerful effect of retatrutide, a first-in-class triple agonist, on body weight, pain and physical function
Objective This review aims to comprehensively summarize the role of GLP-1 RAs in the management of diabetes mellitus (DM) and cardiovascular disease (CVD), with a particular emphasis on the underlying signal transduction pathways and their therapeutic potential
.jpg)
